The role of the implantable cardiac defibrillator in the management

Olaf Hedrich, Gianfranco Buja, Domenico Corrado, Mark S. Link, Thomas Wichter, N. A Mark Estes

Research output: Chapter in Book/Report/Conference proceedingChapter


The management of patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) has evolved considerably over the last several years. Because many patients with ARVC/D may be at risk for sudden cardiac death (SCD) and clinical series have reported favorable outcomes with this therapy, the implantable cardioverter-defibrillator (ICD) has assumed a larger role in therapy. On the basis of collective observations from several series of patients, implantation of an ICD in a patient with ARVC/D has a major impact on decreasing the risk of SCD. This chapter examines the available clinical information regarding ICD therapy in patients with ARVC/D.

Original languageEnglish (US)
Title of host publicationArrhythmogenic RV Cardiomyopathy/Dysplasia
Subtitle of host publicationRecent Advances
PublisherSpringer Milan
Number of pages9
ISBN (Print)9788847004894
StatePublished - Dec 1 2007

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'The role of the implantable cardiac defibrillator in the management'. Together they form a unique fingerprint.

Cite this